Vol 11, No 12 (December 29, 2022): Translational Lung Cancer Research

Editorial

Neoadjuvant chemo-immunotherapy for lung cancer: how much is too much?
Nathaniel Deboever, Jianjun Zhang
Translational Lung Cancer Research  
2022;
11
(12)
:2360-2363
.
 (29 December 2022) 
PDF Full Text (1414) COI Form Open Access Get Permission

Original Article

Preoperative immunochemotherapy for locally advanced non-small cell lung cancer: an analysis of the clinical outcomes, optimal number of cycles, and peripheral immune markers
Hongsheng Deng, Hengrui Liang, Jiawei Chen, Wei Wang, Jianfu Li, Shan Xiong, Bo Cheng, Caichen Li, Zhuxing Chen, Haixuan Wang, Jianqi Zheng, Zhuoxuan Guo, Jianxing He, Wenhua Liang
Translational Lung Cancer Research  
2022;
11
(12)
:2364-2381
.
 (29 December 2022) 
PDF Full Text (2352) Reporting Checklist Data Sharing Statement COI Form Open Access Get Permission
The clinico-pathological characteristics of surgically treated young women with NSCLC
Anna Trojnar, Joanna Domagała-Kulawik, Anna Sienkiewicz-Ulita, Marcin Zbytniewski, Grzegorz M. Gryszko, Marcin M. Cackowski, Michał Dziedzic, Katarzyna Woźnica, Tadeusz M. Orłowski, Dariusz A. Dziedzic; on behalf of the Polish Lung Cancer Study Group (PLCSG)
Translational Lung Cancer Research  
2022;
11
(12)
:2382-2394
.
 (29 December 2022) 
PDF Full Text (1213) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Effectiveness and safety of opioids for dyspnea in patients with lung cancer: secondary analysis of multicenter prospective observational study
Yoshihiko Taniguchi, Yoshinobu Matsuda, Masanori Mori, Madoka Ito, Tomoo Ikari, Akihiro Tokoro, Sayo Aiki, Shunya Hoshino, Daisuke Kiuchi, Kozue Suzuki, Yuko Igarashi, Takuya Odagiri, Kiyofumi Oya, Emi Kubo, Takashi Yamaguchi
Translational Lung Cancer Research  
2022;
11
(12)
:2395-2402
.
 (29 December 2022) 
PDF Full Text (4284) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
The epidemic of malignant mesothelioma in China: a prediction of incidence during 2016–2030
Yirui Zhai, Zhouguang Hui, Wanqing Chen, Jianming Ying, Junling Li, Shugeng Gao
Translational Lung Cancer Research  
2022;
11
(12)
:2403-2411
.
 (29 December 2022) 
PDF Full Text (2519) Reporting Checklist COI Form Open Access Get Permission
PD-1/PD-L1 inhibitor activity in patients with gene-rearrangement positive non-small cell lung cancer—an IMMUNOTARGET case series
Rao Mushtaq, Alexis B. Cortot, Oliver Gautschi, Julien Mazieres, D. Ross Camidge
Translational Lung Cancer Research  
2022;
11
(12)
:2412-2417
.
 (29 December 2022) 
PDF Full Text (1297) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Adjuvant chemotherapy for completely resected IIA–IIIA non-small cell lung cancer: compliance to guidelines, safety and efficacy in real-life practice
Anne-Laure Désage, Claire Tissot, Sophie Bayle-Bleuez, Thierry Muron, Nadine Deygas, Valérie Grangeon-Vincent, Brigitte Monange, Fatah Torche, Paul Vercherin, David Kaczmarek, Olivier Tiffet, Fabien Forest, Jean-Michel Vergnon, Wafa Bouleftour, Pierre Fournel
Translational Lung Cancer Research  
2022;
11
(12)
:2418-2437
.
 (29 December 2022) 
PDF Full Text (1730) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
SP142 evaluation contributes to the prediction of immune checkpoint inhibitor efficacy in non-small cell lung cancer with high PD-L1 expression assessed by 22C3
Kenji Nakahama, Masahiko Osawa, Motohiro Izumi, Naoki Yoshimoto, Akira Sugimoto, Hiroaki Nagamine, Koichi Ogawa, Yoshiya Matsumoto, Kenji Sawa, Yoko Tani, Hiroyasu Kaneda, Shigeki Mitsuoka, Tetsuya Watanabe, Kazuhisa Asai, Tomoya Kawaguchi
Translational Lung Cancer Research  
2022;
11
(12)
:2438-2451
.
 (29 December 2022) 
PDF Full Text (1670) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Impact of image filtering and assessment of volume-confounding effects on CT radiomic features and derived survival models in non-small cell lung cancer
Stefania Volpe, Lars Johannes Isaksson, Mattia Zaffaroni, Matteo Pepa, Sara Raimondi, Francesca Botta, Giuliana Lo Presti, Maria Giulia Vincini, Cristiano Rampinelli, Marta Cremonesi, Filippo de Marinis, Lorenzo Spaggiari, Sara Gandini, Matthias Guckenberger, Roberto Orecchia, Barbara Alicja Jereczek-Fossa
Translational Lung Cancer Research  
2022;
11
(12)
:2452-2463
.
 (29 December 2022) 
PDF Full Text (1828) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Landscape and clinical impact of metabolic alterations in non-squamous non-small cell lung cancer
Anna V. Ivanina Foureau, Wei Sha, David M. Foureau, James T. Symanowski, Carol J. Farhangfar, Kathryn F. Mileham
Translational Lung Cancer Research  
2022;
11
(12)
:2464-2476
.
 (29 December 2022) 
PDF Full Text (1667) Reporting Checklist COI Form Open Access Get Permission
Comparison of ROS1-rearrangement detection methods in a cohort of surgically resected non-small cell lung carcinomas
Viktoria Thurfjell, Patrick Micke, Hui Yu, Rosemarie Krupar, Maria A. Svensson, Hans Brunnström, Kristina Lamberg, Lotte N. J. Moens, Carina Strell, Miklos Gulyas, Gisela Helenius, Akihiko Yoshida, Torsten Goldmann, Johanna Sofia Margareta Mattsson
Translational Lung Cancer Research  
2022;
11
(12)
:2477-2494
.
 (29 December 2022) 
PDF Full Text (2474) Reporting Checklist Data Sharing Statement COI Form Open Access Get Permission
Alectinib as first-line treatment for advanced ALK-positive non-small cell lung cancer in the real-world setting: preliminary analysis in a Chinese cohort
Zihua Zou, Yangchun Gu, Li Liang, Xuezhi Hao, Chengjuan Fan, Tao Xin, Songchen Zhao, Ziling Liu, Ye Guo, Kewei Ma, Haojing Li, Cuiying Zhang, Li Shan, Yan Zhang, Guilan Dong, Yumei Peng, Fangfang Shen, Xia Song, Petros Christopoulos, Anthonie J. van der Wekken, Katsuhiro Okuda, Simon Ekman, Puyuan Xing, Junling Li
Translational Lung Cancer Research  
2022;
11
(12)
:2495-2506
.
 (29 December 2022) 
PDF Full Text (2454) Reporting Checklist Data Sharing Statement COI Form Open Access Get Permission
Immunotherapy with radiotherapy fails to improve prognosis of patients with stage IV non-small cell lung cancer: a retrospective cohort analysis of the THUNDER-2 study
Li Liu, Meng Yuan, Zhaolei Ding, Hui Feng, Xiaotao Zhang, Ning Liang, Wei Wang, Jun Wang, Yan Zhang, Shengjian Zhou, Anthony W. Kim, Simona Castiglioni, Rafal Suwinski, Hang Wang, Pingping Hu, Jiandong Zhang
Translational Lung Cancer Research  
2022;
11
(12)
:2507-2520
.
 (29 December 2022) 
PDF Full Text (1524) Reporting Checklist Data Sharing Statement COI Form Open Access Get Permission
Efficacy and safety of alectinib in ALK-positive non-small cell lung cancer and blood markers for prognosis and efficacy: a retrospective cohort study
Yingying Jiang, Yue Shi, Yiling Liu, Zihan Wang, Yuxin Ma, Xinhong Shi, Lin Lu, Zhitong Wang, Hang Li, Yushu Zhang, Caolu Liu, Shaorui Zhang, Zhihao Zhong, Jianwei Lu, Meiqi Shi, Bo Shen, Guoren Zhou, Rong Yin, Domenico Galetta, Anna Grenda, Atocha Romero, Brett G. M. Hughes, Cheng Chen, Xiaohua Wang, Jifeng Feng
Translational Lung Cancer Research  
2022;
11
(12)
:2521-2538
.
 (29 December 2022) 
PDF Full Text (2224) Reporting Checklist Data Sharing Statement COI Form Open Access Get Permission
DNA damage repair gene mutations predict the efficacy of platinum-based chemotherapy and immunotherapy plus platinum-based chemotherapy in advanced non-small cell lung cancer: a retrospective Chinese cohort study
Zhiwei Xiao, Lingling Sun, Yating Zheng, Hanrui Chen, Xinting Zheng, Jiamin Luo, Chuying Gu, Ruiting Lin, Mengli Huang, Yuezong Bai, Zhe-Sheng Chen, Connor J. Kinslow, Jerold Loh, Lizhu Lin
Translational Lung Cancer Research  
2022;
11
(12)
:2539-2566
.
 (29 December 2022) 
PDF Full Text (2417) Reporting Checklist Data Sharing Statement COI Form Open Access Get Permission

Review Article

A multidisciplinary approach to the work up and management of pulmonary carcinoid tumors and DIPNECH: a narrative review
Robert A. Ramirez, Amanda S. Cass, Satya Das, See-Wei Low, Mitra Mehrad, Otis B. Rickman, Philip M. Scherer, Katharine E. Thomas, Erin A. Gillaspie
Translational Lung Cancer Research  
2022;
11
(12)
:2567-2587
.
 (29 December 2022) 
PDF Full Text (5065) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Role of ctDNA for the detection of minimal residual disease in resected non-small cell lung cancer: a systematic review
Michela Verzè, Monica Pluchino, Alessandro Leonetti, Matilde Corianò, Francesco Bonatti, Maria P. Armillotta, Fabiana Perrone, Miriam Casali, Roberta Minari, Marcello Tiseo
Translational Lung Cancer Research  
2022;
11
(12)
:2588-2600
.
 (29 December 2022) 
PDF Full Text (3658) Reporting Checklist Peer Review File COI Form Open Access Get Permission

Case Report

Three non-small cell lung cancer patients who developed pulmonary thromboses during osimertinib treatment and could safely resume concomitant anticoagulation treatment: a report of three cases
Satoshi Shoji, Satoshi Watanabe, Yusuke Hanazawa, Toshiya Fujisaki, Toshiaki Kikuchi
Translational Lung Cancer Research  
2022;
11
(12)
:2601-2607
.
 (29 December 2022) 
PDF Full Text (1899) Reporting Checklist Peer Review File COI Form Open Access Get Permission

Erratum

Erratum to clinical features and prognosis of resectable pulmonary primary invasive mucinous adenocarcinoma
Editorial Office
Translational Lung Cancer Research  
2022;
11
(12)
:2608-2609
.
 (29 December 2022) 
PDF Full Text (807) Open Access Get Permission
Erratum to efficacy evaluation of surgery combined with chemotherapy for stage IIIA small cell lung cancer patients: a retrospective analysis
Editorial Office
Translational Lung Cancer Research  
2022;
11
(12)
:2610-2611
.
 (29 December 2022) 
PDF Full Text (502) Open Access Get Permission